Anbc, Inc. (SYUP)
OTCMKTS · Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
At close: May 7, 2025

Anbc, Inc. Company Description

Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People’s Republic of China.

Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral solution that relieves cough and dyspnea; Shen-bao, a syrup for the treatment of impotence and spermatorrhoea; Ban-xia, a syrup that relieves cough; and Gan-mao-zhi-ke, a syrup that relieves flu symptoms, cough, and nasal congestion.

It also offers Ban-lan-gen that relieves cold and flu symptoms; Gan-mao-qing-re that relieves minor body aches and pains, and reduces fever; Huang-dan-yin-chen used in the treatment for jaundice infection hepatitis; and Liu-shen-qu for treatment of vomitings and dysentery.

It offers its products to distributors on a wholesale basis. The company is based in Shanghai, China.

Anbc, Inc.
Country United States
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
CEO Wei Dong

Contact Details

Address:
No 2020 Huqingping Road
Shanghai, Delaware 201702
China
Phone 86 21 5976 0042

Stock Details

Ticker Symbol SYUP
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US00180L1052
SIC Code 2834

Key Executives

Name Position
Wei Dong Chief Executive Officer
Lu Jiang'an President, Principal Financial Officer and Principal Accounting Officer
Lee Lishia Secretary and Treasurer